Time to make your list too! As regular readers of this blog are well aware, I think that some sort of correction is in the offing, if not now, probably within the next six months. I remain skeptical of whether current market levels can be maintained in what I see as signs of rising inflation, which must ultimately be met by rising interest rates. Against a backdrop of PE ratios at or above historical norms, I believe that this sets the stage for a market decline.
So while I've raised some cash in my portfolio, I happily await the correction. This should give me the opportunity to purchase some of my desired stocks and ETFs at nice discounts. I'm hoping for some of the following top-quality names to drop far enough for me to purchase nice big chunks that'll fuel my portfolio for awhile to come. Some of the blue-chip names I'll be following include:
- Coke (KO)
- Pfizer (PFE)
- Brookfield Asset Management (BAM)
- Wells Fargo (WFC)
- Goldman Sachs (GS)
- Procter & Gamble (PG)
- Manulife Financial (MFC)
So, during this phoney war, don't waste your time either. Make your list and check it twice too.
The Confused Capitalist